// App-Quantinova.ai

632 : Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-?2-Glycoprotein I IgG Elisas Influences the Diagnosis of the Antiphospholipid Syndrome

Researchers

Presenter

  • Hilde Kelchtermans

Principal Investigators

  • Marisa Ninivaggi

  • Theo Lindhout

  • Philip G de Groot

  • Vittorio Pengo

  • Bas De Laat

Medical Centers

  • Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands

  • Cardiothoracic and Vascular Sciences, Clinical Cardiology, Padua, Italy

  • Synapse BV, Maastricht, Netherlands

Locations

  • Italy

  • Netherlands

Companies

  • Sanquin

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim